- Home
- DGX vs WAT Comparison
DGX vs WAT Comparison
Compare DGX & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGX
- WAT
- Stock Information
- Founded
- DGX 1967
- WAT 1958
- Country
- DGX United States
- WAT United States
- Employees
- DGX N/A
- WAT N/A
- Industry
- DGX Medical Specialities
- WAT Biotechnology: Laboratory Analytical Instruments
- Sector
- DGX Health Care
- WAT Industrials
- Exchange
- DGX Nasdaq
- WAT Nasdaq
- Market Cap
- DGX 19.2B
- WAT 21.9B
- IPO Year
- DGX 1996
- WAT 1995
- Fundamental
- Price
- DGX $167.31
- WAT $361.93
- Analyst Decision
- DGX Buy
- WAT Buy
- Analyst Count
- DGX 13
- WAT 14
- Target Price
- DGX $178.38
- WAT $393.00
- AVG Volume (30 Days)
- DGX 1.2M
- WAT 473.8K
- Earning Date
- DGX 04-22-2025
- WAT 05-06-2025
- Dividend Yield
- DGX 1.91%
- WAT N/A
- EPS Growth
- DGX 2.67
- WAT N/A
- EPS
- DGX 7.69
- WAT 10.71
- Revenue
- DGX $9,872,000,000.00
- WAT $2,958,387,000.00
- Revenue This Year
- DGX $10.28
- WAT $4.99
- Revenue Next Year
- DGX $3.84
- WAT $6.12
- P/E Ratio
- DGX $21.76
- WAT $33.82
- Revenue Growth
- DGX 6.70
- WAT 0.07
- 52 Week Low
- DGX $125.42
- WAT $279.24
- 52 Week High
- DGX $178.87
- WAT $423.56
- Technical
- Relative Strength Index (RSI)
- DGX 47.83
- WAT 40.85
- Support Level
- DGX $164.61
- WAT $355.00
- Resistance Level
- DGX $168.14
- WAT $377.52
- Average True Range (ATR)
- DGX 3.50
- WAT 11.26
- MACD
- DGX -0.78
- WAT -0.46
- Stochastic Oscillator
- DGX 36.28
- WAT 18.50
About DGX Quest Diagnostics Incorporated
Quest Diagnostics Inc is a leading independent provider of diagnostic testing, information, and services in the us. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2023, Waters generated 57% from biopharmaceutical customers, 31% from industrial clients, and 12% from academic/government institutions.